Literature DB >> 33834679

[Advances in molecular mechanisms of bone invasion by oral cancer].

Wei Liu1, Chun-Jie Li1, Long-Jiang Li1.   

Abstract

Bone invasion by oral cancer is a common clinical problem, which affects the choice of treatment and predicts a poor prognosis. Unfortunately, the molecular mechanism of this phenomenon has not been fully elucidated. Current studies have revealed that oral cancer cells modulate the formation and function of osteoclasts through the expression of a series of signal molecules. Many signal pathways are involved in this process, of which receptor activator of nuclear factor-κB ligand/receptor activator of nuclear factor-κB/osteoprotegerin signaling pathway attracted much attention. In this review, we introduce recent progress in molecular mechanisms of bone invasion by oral cancer.

Entities:  

Keywords:  bone invasion; molecular mechanism; oral cancer; osteoclast

Mesh:

Substances:

Year:  2021        PMID: 33834679      PMCID: PMC8055778          DOI: 10.7518/hxkq.2021.02.015

Source DB:  PubMed          Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi        ISSN: 1000-1182


  47 in total

1.  Molecular pathways involved in crosstalk between cancer cells, osteoblasts and osteoclasts in the invasion of bone by oral squamous cell carcinoma.

Authors:  Jingjing Quan; Chuanxiang Zhou; Newell W Johnson; Glenn Francis; Jane E Dahlstrom; Jin Gao
Journal:  Pathology       Date:  2012-04       Impact factor: 5.306

2.  Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo.

Authors:  Hiroyuki Furuta; Kenji Osawa; Masashi Shin; Ayataka Ishikawa; Kou Matsuo; Masud Khan; Kazuhiro Aoki; Keiichi Ohya; Masato Okamoto; Kazuhiro Tominaga; Tetsu Takahashi; Osamu Nakanishi; Eijiro Jimi
Journal:  Int J Cancer       Date:  2012-02-23       Impact factor: 7.396

3.  Parathyroid-related protein plays a critical role in bone invasion by oral squamous cell carcinoma.

Authors:  Yuki Takayama; Taisuke Mori; Takeshi Nomura; Takahiko Shibahara; Michiie Sakamoto
Journal:  Int J Oncol       Date:  2010-06       Impact factor: 5.650

4.  Establishment of a xenograft model to explore the mechanism of bone destruction by human oral cancers and its application to analysis of role of RANKL.

Authors:  Rei Tohyama; Kou Kayamori; Kiyoshi Sato; Miwako Hamagaki; Kei Sakamoto; Hisataka Yasuda; Akira Yamaguchi
Journal:  J Oral Pathol Med       Date:  2015-10-13       Impact factor: 4.253

Review 5.  Patterns and mechanisms of localized bone invasion by tumors: studies with squamous carcinomas of the head and neck.

Authors:  R L Carter
Journal:  Crit Rev Clin Lab Sci       Date:  1985       Impact factor: 6.250

6.  RANKL synthesized by both stromal cells and cancer cells plays a crucial role in osteoclastic bone resorption induced by oral cancer.

Authors:  Kiyoshi Sato; Ji-Won Lee; Kei Sakamoto; Tadahiro Iimura; Kou Kayamori; Hisataka Yasuda; Masanobu Shindoh; Masako Ito; Ken Omura; Akira Yamaguchi
Journal:  Am J Pathol       Date:  2013-03-15       Impact factor: 4.307

7.  Oral squamous cell carcinomas stimulate osteoclast differentiation.

Authors:  Yoshiaki Deyama; Kanchu Tei; Yoshitaka Yoshimura; Yuri Izumiyama; Sadaaki Takeyama; Mitsutoki Hatta; Yasunori Totsuka; Kuniaki Suzuki
Journal:  Oncol Rep       Date:  2008-09       Impact factor: 3.906

8.  Utilization of E-cadherin by monocytes from tumour cells plays key roles in the progression of bone invasion by oral squamous cell carcinoma.

Authors:  Jingjing Quan; Qian Du; Yuluan Hou; Zhiyuan Wang; Jingyuan Zhang
Journal:  Oncol Rep       Date:  2017-06-23       Impact factor: 3.906

9.  Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.

Authors:  Junhee Park; Hyun-Jeong Kim; Ki Rim Kim; Sun Kyoung Lee; Hyungkeun Kim; Kwang-Kyun Park; Won-Yoon Chung
Journal:  Oncotarget       Date:  2017-02-07

10.  The Role of Sonic Hedgehog Signaling in Osteoclastogenesis and Jaw Bone Destruction.

Authors:  Tsuyoshi Shimo; Kenichi Matsumoto; Kiyofumi Takabatake; Eriko Aoyama; Yuichiro Takebe; Soichiro Ibaragi; Tatsuo Okui; Naito Kurio; Hiroyuki Takada; Kyoichi Obata; Pai Pang; Masahiro Iwamoto; Hitoshi Nagatsuka; Akira Sasaki
Journal:  PLoS One       Date:  2016-03-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.